139 related articles for article (PubMed ID: 8215637)
1. The development of gene therapy for the treatment of cancer.
Rosenberg SA; Anderson WF; Blaese M; Hwu P; Yannelli JR; Yang JC; Topalian SL; Schwartzentruber DJ; Weber JS; Ettinghausen SE
Ann Surg; 1993 Oct; 218(4):455-63; discussion 463-4. PubMed ID: 8215637
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin.
Merrouche Y; Negrier S; Bain C; Combaret V; Mercatello A; Coronel B; Moskovtchenko JF; Tolstoshev P; Moen R; Philip T
J Clin Oncol; 1995 Feb; 13(2):410-8. PubMed ID: 7844602
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
Ogasawara M; Rosenberg SA
Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
[TBL] [Abstract][Full Text] [Related]
4. Prospects for gene therapy and lymphokine therapy for metastatic melanoma.
Sivanandham M; Scoggin SD; Sperry RG; Wallack MK
Ann Plast Surg; 1992 Jan; 28(1):114-8. PubMed ID: 1642399
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.
Rosenberg SA; Aebersold P; Cornetta K; Kasid A; Morgan RA; Moen R; Karson EM; Lotze MT; Yang JC; Topalian SL
N Engl J Med; 1990 Aug; 323(9):570-8. PubMed ID: 2381442
[TBL] [Abstract][Full Text] [Related]
6. Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man.
Kasid A; Morecki S; Aebersold P; Cornetta K; Culver K; Freeman S; Director E; Lotze MT; Blaese RM; Anderson WF
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):473-7. PubMed ID: 2404283
[TBL] [Abstract][Full Text] [Related]
7. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.
Goedegebuure PS; Douville LM; Li H; Richmond GC; Schoof DD; Scavone M; Eberlein TJ
J Clin Oncol; 1995 Aug; 13(8):1939-49. PubMed ID: 7636534
[TBL] [Abstract][Full Text] [Related]
8. Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans.
Hwu P; Yannelli J; Kriegler M; Anderson WF; Perez C; Chiang Y; Schwarz S; Cowherd R; Delgado C; Mulé J
J Immunol; 1993 May; 150(9):4104-15. PubMed ID: 8473752
[TBL] [Abstract][Full Text] [Related]
9. The genetic modification of T cells for cancer therapy: an overview of laboratory and clinical trials.
Hwu P; Rosenberg SA
Cancer Detect Prev; 1994; 18(1):43-50. PubMed ID: 8162605
[TBL] [Abstract][Full Text] [Related]
10. Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector.
Nash MA; Platsoucas CD; Wong BY; Wong PM; Cottler-Fox M; Otto E; Freedman RS
Hum Gene Ther; 1995 Nov; 6(11):1379-89. PubMed ID: 8573611
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tumor-necrosis-factor-gene-transduced tumor-infiltrating lymphocytes from ascitic fluid of cancer patients: analysis of cytolytic activity, growth rate, adhesion molecule expression and cytokine production.
Itoh Y; Koshita Y; Takahashi M; Watanabe N; Kohgo Y; Niitsu Y
Cancer Immunol Immunother; 1995 Feb; 40(2):95-102. PubMed ID: 7882388
[TBL] [Abstract][Full Text] [Related]
12. Selection of gene-marked tumor infiltrating lymphocytes from post-treatment biopsies: a case study.
Aebersold P; Kasid A; Rosenberg SA
Hum Gene Ther; 1990; 1(4):373-84. PubMed ID: 1964094
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for cancer.
Rosenberg SA
JAMA; 1992 Nov; 268(17):2416-9. PubMed ID: 1404800
[TBL] [Abstract][Full Text] [Related]
14. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients.
Besser MJ; Shapira-Frommer R; Treves AJ; Zippel D; Itzhaki O; Hershkovitz L; Levy D; Kubi A; Hovav E; Chermoshniuk N; Shalmon B; Hardan I; Catane R; Markel G; Apter S; Ben-Nun A; Kuchuk I; Shimoni A; Nagler A; Schachter J
Clin Cancer Res; 2010 May; 16(9):2646-55. PubMed ID: 20406835
[TBL] [Abstract][Full Text] [Related]
15. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
Hwu P; Yang JC; Cowherd R; Treisman J; Shafer GE; Eshhar Z; Rosenberg SA
Cancer Res; 1995 Aug; 55(15):3369-73. PubMed ID: 7614473
[TBL] [Abstract][Full Text] [Related]
16. Tumor tissue recycling--a new combination treatment for solid tumors: experimental and preliminary clinical research.
Li B; Ding J; Larson A; Song S
In Vivo; 1999; 13(5):433-8. PubMed ID: 10654199
[TBL] [Abstract][Full Text] [Related]
17. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns.
Yamamoto T; Kimura T; Ueta E; Tatemoto Y; Osaki T
Oncology; 2003; 64(4):407-15. PubMed ID: 12759539
[TBL] [Abstract][Full Text] [Related]
18. Cancer therapy with tumor-infiltrating lymphocytes: evaluation of potential and limitations.
Whiteside TL
In Vivo; 1991; 5(6):553-9. PubMed ID: 1810438
[TBL] [Abstract][Full Text] [Related]
19. The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens.
Rosenberg SA
Annu Rev Med; 1996; 47():481-91. PubMed ID: 8712798
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI
Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
